Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Capital Contingent Convertible (AT1) in the amount of MUSD 1000
Mandate

Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Capital Contingent Convertible (AT1) in the amount of MUSD 1000 

October 07, 2020 Banking and Finance

Vinge has advised Morgan Stanley & Co. International plc and the other arranging banks consisting of Barclays Bank PLC, Citigroup Global Markets Limited, J.P. Morgan Securities plc and Svenska Handelsbanken AB (publ) in respect of Swedish law in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Contingent Convertible Notes (AT1 CoCo). The issuance amount is USD 1,000 million in two tranches of USD 500 million each, at interest rates of 4.375 and 4.75 per cent respectively.

The loans are perpetual without a final maturity date but the Bank has the option to redeem the loans after 6.5 years (March 2027) and 10.5 years (March 2031), and then subsequently every fifth year. The issuance of AT1 is in the form of debt instruments with automatic conversion to class A-shares, if the Bank’s common equity tier 1 ratio (CET1) falls below a certain level.
The issuance of additional AT1 capital is part of the bank’s capital planning.
The issuance was subscribed by and allotted to the joint lead managers on 6 October 2020 and have been listed on the Global Exchange Market of Euronext Dublin.
Vinge’s team consisted of responsible partner Mikael Ståhl, Paulina Malmberg and Malte St Cyr Ohm. 

 

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026